Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Health Catalyst ( (HCAT) ) has issued an update.
On September 10, 2025, Health Catalyst announced the appointment of Ben Albert as President and Chief Operating Officer, effective September 16, 2025. Albert, who previously led Upfront Healthcare Services, will guide Health Catalyst through a pivotal phase, focusing on long-term success and operational leadership. This transition is part of a broader leadership change, as current CEO Dan Burton plans to retire in June 2026, with Albert working closely alongside him to ensure continuity and stability. The appointment aims to enhance Health Catalyst’s progress and shareholder value, leveraging Albert’s extensive experience in healthcare technology.
The most recent analyst rating on (HCAT) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Health Catalyst stock, see the HCAT Stock Forecast page.
Spark’s Take on HCAT Stock
According to Spark, TipRanks’ AI Analyst, HCAT is a Neutral.
Health Catalyst’s overall stock score reflects significant challenges in financial performance, with ongoing profitability issues and negative cash flows. The technical analysis indicates a bearish trend, while the valuation is unattractive due to a negative P/E ratio. Despite positive strategic initiatives and earnings call highlights, macroeconomic challenges and funding cuts weigh heavily on the company’s outlook.
To see Spark’s full report on HCAT stock, click here.
More about Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. The company offers a cloud-based technology ecosystem, AI-enabled data and analytics solutions, and expert services to drive clinical, financial, and operational improvements. Health Catalyst serves over 1,000 organizations worldwide, transforming complex information into actionable insights to achieve measurable healthcare improvements.
Average Trading Volume: 747,296
Technical Sentiment Signal: Sell
Current Market Cap: $237.9M
For a thorough assessment of HCAT stock, go to TipRanks’ Stock Analysis page.